Intravitreal Therapy for Uveitic Macular Edema – Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results

February 2024  Jordan D. Deaner, MD Uveitis and Vitreoretinal Surgery Mid Atlantic Retina, Wills Eye Hospital Assistant Professor, Thomas Jefferson University Philadelphia, PA   Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee:; Acharya NR, Vitale AT, Sugar EA, Holbrook JT, Burke AE, Thorne JE, Altaweel MM, Kempen JH, Jabs DA. Intravitreal Therapy for […]

Four-Year Outcomes in Protocol W

May 2023   Kyle Davis Kovacs, MD Weill Cornell Medicine, New York, NY Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept […]

iERM: Immediate Versus Deferred Surgery

March 2023 Joshua Uhr, MD Location/Affiliation: Retinal and Ophthalmic Consultants, PC Northfield, NJ Al-Khersan H, Shaheen AR, Flynn HW Jr, Smiddy WE. Natural History and Surgical Timing for Idiopathic Epiretinal Membrane. Ophthalmol Retina. 2022 Nov;6(11):978-984. doi: 10.1016/j.oret.2022.02.014. Epub 2022 Mar 8. PMID: 35272083. The authors studied the natural history of idiopathic epiretinal membrane (iERM) and […]

RPD and Higher Risk of Progression to Late AMD

February 2023 Youning Zhang, MD Location/Affiliation: Los Angeles, Olive View – UCLA Medical Center Agron E, Domalpally A, Cukras C, Clemons TE, Chen Q, Lu Z, Chew EY, Keenan TDL, for the AREDS and AREDS2 Research Group. Ophthalmology 2022;129:1107-1119. Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration. doi: 10.1016/j.ophtha.2022.05.021. […]

Optimal Timing for RRD Repair

February 2023 Written by: Monique Munro, MD, FRCSC Locum with University of Calgary, Section of Ophthalmology Calgary, AB, Canada Sothivannan A, Eshtiaghi A, Dhoot AS, Popovic MM, Garg SJ, Kertes PJ, Muni RH. Impact of the Time to Surgery on Visual Outcomes for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis. Am J Ophthalmol. 2022 Dec;244:19-29.  Visual […]

Air Versus Gas Tamponade for Small- and Medium-Sized Macular Holes

February 2023 Written by: Wasim Samara, MD Taylor Retina Center Raleigh, NC Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S, Fossen K, Varhaug P, Kvaløy JT, Forsaa VA. Air versus Sulfur Hexafluoride Gas Tamponade for Small and Medium-Sized Macular Holes: A Randomized Noninferiority Trial. Ophthalmol Retina. 2022 Sep;6(9):828-834. doi: 10.1016/j.oret.2022.04.003. Epub […]

Drainage Retinotomy is a Risk Factor for Surgical Failure after Pars Plana Vitrectomy in Patients with Primary Uncomplicated Rhegmatogenous Retinal Detachment

January 2023 Written by: Tamara Lee Lenis, MD PhD NJ Retina Ohara H, Yuasa Y, Harada Y, Hiyama T, Sadahide A, Minamoto A, Hirooka K, Kiuchi Y. DRAINAGE RETINOTOMY IS A RISK FACTOR FOR SURGICAL FAILURE AFTER PARS PLANA VITRECTOMY IN PATIENTS WITH PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT. Retina. 2022 Dec 1;42(12):2307-2314. doi: 10.1097/IAE.0000000000003608. PMID: […]

Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment – ELLIPSOID Study

January 2023 Written by:  Priya Vakharia, MD Retina Vitreous Associates of Florida Tampa Bay, FL McKay BR, Bansal A, Kryshtalskyj M, Wong DT, Berger A, Muni RH. Evaluation of Subretinal fluid Drainage Techniques During Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment-ELLIPSOID Study. Am J Ophthalmol. 2022 Sep;241:227-237. doi: 10.1016/j.ajo.2022.05.008. Epub 2022 May 18. PMID: 35597323. This […]